Healios KK Ord Shs HLOSF

Healthcare Biotechnology

HEALIOS K.K. is a Japan-based company mainly engaged in research and development of pharmaceutical products. The Company has compound pharmaceutical products line and induced pluripotent stem cell (iPSC) regenerative medicine product line. The compound pharmaceutical product line contains HLM0021, HLM0022 and HLM0023. The products are ophthalmological surgery adjuvants, mainly contain brilliant blue G-250 (BBG250) which help capsule temporarily safely stained to protect the inner limiting membranes and lens during surgery of vitreous and cataract. The iPSC regenerative medicine product line contains HLCR011 and HLCR012. The products are in the preclinical testing and preparation for trial in Japan, which are candidate of regenerative medicine products. The products are iPS cell derived retinal pigment epithelium (RPE) cell suspension and sheet developed in Japan, United States and Europe.

PINL:HLOSF - Post by User

Healios KK Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by Camaronion Apr 17, 2013 7:36am

210 Views

Post# 21277513

An finally a reply which is epically useless

Sent a secon message askinng for prospective date of this proposed merger of equals and this what i heard back......

Hi. This is the qmail-send program at plesk-cg5.sherweb.com.I'm afraid I wasn't able to deliver your message to the following addresses.This is a permanent error; I've given up. Sorry it didn't work out. <ir@halores.com>:Recipient's mailbox is full, message returned to sender.

<< Previous

Bullboard Posts

Next >>

Silvercorp to expand into Ecuador with C$200M Adventus acquisition